Lung and Upper Aerodigestive Cancer

The Lung and Upper Aerodigestive Cancer Research Group conducts and supports research on the prevention and early detection of lung and head and neck cancers, as well as new approaches to clinical prevention studies including cancer immunoprevention.

Read more About the Lung and Upper Aerodigestive Cancer Research Group.

Staff

Funding Opportunities

Grants

Clinical Trials

Publications

Cancer Prevention Clinical Trials Network (CP-CTNet)

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Major medical research centers conduct systematic early clinical development of promising preventive agents.

Small Cell Lung Cancer (SCLC) Consortium

Six investigators conduct research to expand the understanding of the critical molecular changes in the lung that precede the development of frank SCLC and/or to identify populations at particularly high risk for SCLC.

News and Events

2023 “Investigators' and Site Coordinators' Opportunity for Research Excellence” (I-SCORE) HYBRID meeting
Date Posted: February 8, 2023

Leveraging Artificial Intelligence to Improve Accuracy of Lung Cancer Screening
Date Posted: December 16, 2022

Identifying New Biomarkers to Detect Lung Cancer Earlier
Date Posted: January 14, 2022